PAPER Devanarayan V, Llano DA, Hu YH, Hampel H, Kramer L, Dhadda S, Irizarry M
SEARCH RESULTS
335775 RESULTS
PAPER Ding Z, Chan AS
The Shape Trail Test Is Sensitive in Differentiating Older Adults with Mild Cognitive Impairment: A Culture-neutral Five-minute Test.
J Prev Alzheimers Dis. 2024;11(4):1166-1176. PubMed.PAPER Leow YJ, Wang JD, Vipin A, Sandhu GK, Soo SA, Kumar D, Mohammed AA, Zailan FZ, Lee FP, Ghildiyal S, Liew SY, Dang C, Tanoto P, Tan IY, Chong WF, Kandiah N
Biomarkers and Cognition Study, Singapore (BIOCIS): Protocol, Study Design, and Preliminary Findings.
J Prev Alzheimers Dis. 2024;11(4):1093-1105. PubMed.PAPER Giuffrè GM, Quaranta D, Vita MG, Costantini EM, Citro S, Carrozza C, De Ninno G, Calabresi P, Marra C
Performance of Fully-Automated High-Throughput Plasma Biomarker Assays for Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subjects.
J Prev Alzheimers Dis. 2024;11(4):1073-1078. PubMed.PAPER Censi S, Sestieri C, Punzi M, Delli Pizzi A, Ferretti A, Gambi F, Tomassini V, Delli Pizzi S, Sensi SL
"Back to Braak": Role of Nucleus Reuniens and Subcortical Pathways in Alzheimer's Disease Progression.
J Prev Alzheimers Dis. 2024;11(4):1030-1040. PubMed.PAPER Dickson SP, Solomon A, Kivipelto M, Hartmann T, van Hees AM, Brownlee A, Haaland B, Mallinckrodt CH, Hendrix SB
Evaluation of Clinical Meaningfulness of Fortasyn Connect in Terms of "Time Saved".
J Prev Alzheimers Dis. 2024;11(4):992-997. PubMed.PAPER Frech FH, Li G, Juday T, Ding Y, Mattke S, Khachaturian A, Rosenberg AS, Ndiba-Markey C, Rava A, Batrla R, De Santi S, Hampel H
Economic Impact of Progression from Mild Cognitive Impairment to Alzheimer Disease in the United States.
J Prev Alzheimers Dis. 2024;11(4):983-991. PubMed.PAPER Mimmack KJ, Sprague EH, Amariglio RE, Vannini P, Marshall GA
Longitudinal Evolution of Financial Capacity and Cerebral Tau and Amyloid Burden in Older Adults with Normal Cognition or Mild Cognitive Impairment.
J Prev Alzheimers Dis. 2024;11(4):966-974. PubMed.PAPER Wang Y, Ren D, Roberts JS, Tamres LK, Lingler JH
Value of Knowing: Health-Related Behavior Changes following Amyloid PET Results Disclosure in Mild Cognitive Impairment.
J Prev Alzheimers Dis. 2024;11(4):958-965. PubMed.PAPER Cheng Y, Ho E, Weintraub S, Rentz D, Gershon R, Das S, Dodge HH
Predicting Brain Amyloid Status Using the National Institute of Health Toolbox (NIHTB) for Assessment of Neurological and Behavioral Function.
J Prev Alzheimers Dis. 2024;11(4):943-957. PubMed.PAPER Wu HS, Li L, Sun QQ, Tan CC, Tan L, Xu W
Predicting Cognitive Decline for Non-Demented Adults with High Burden of Tau Pathology, Independent of Amyloid Status.
J Prev Alzheimers Dis. 2024;11(4):908-916. PubMed.PAPER Sperling RA, Donohue MC, Rissman RA, Johnson KA, Rentz DM, Grill JD, Heidebrink JL, Jenkins C, Jimenez-Maggiora G, Langford O, Liu A, Raman R, Yaari R, Holdridge KC, Sims JR, Aisen PS
Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies.
J Prev Alzheimers Dis. 2024;11(4):802-813. PubMed.PAPER Lyu C, Siu K, Xu I, Osman I, Zhong J
Social Isolation Changes and Long-Term Outcomes Among Older Adults.
JAMA Netw Open. 2024 Jul 1;7(7):e2424519. PubMed.PAPER Prajapati SK, Pathak A, Samaiya PK
Alzheimer's disease: from early pathogenesis to novel therapeutic approaches.
Metab Brain Dis. 2024 Jul 24; PubMed.PAPER Kondo S, Ishibashi K, Ishii K, Iwata A, Ihara R
Clinical Application of 18F-THK5351 PET to Image Ongoing Astrogliosis in MSA-P and MSA-C.
Clin Nucl Med. 2024 Jul 22; PubMed.Current Filters
No filters selected